These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 19690493)

  • 41. Physiological distribution of placental growth factor and soluble Flt-1 in early pregnancy.
    Makrydimas G; Sotiriadis A; Savvidou MD; Spencer K; Nicolaides KH
    Prenat Diagn; 2008 Mar; 28(3):175-9. PubMed ID: 18264952
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Prognostic significance of preoperative serum CA 19.9 assay in patients with colorectal carcinoma.
    Diez M; Cerdán FJ; Pollán M; Maestro ML; Ortega MD; Martínez S; Moreno G; Balibrea JL
    Anticancer Res; 1994; 14(6B):2819-25. PubMed ID: 7872725
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Serum vascular endothelial growth factor levels in patients with colorectal cancer and its prognostic significance].
    Cubo T; Padilla D; de la Osa G; Palomino T; García M; Pardo R; Martín J; Arévalo E; Hernández J
    Med Clin (Barc); 2004 Feb; 122(6):201-4. PubMed ID: 15012886
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Vascular endothelial growth factor (VEGF)--a valuable serum tumour marker in patients with colorectal cancer?
    Broll R; Erdmann H; Duchrow M; Oevermann E; Schwandner O; Markert U; Bruch HP; Windhövel U
    Eur J Surg Oncol; 2001 Feb; 27(1):37-42. PubMed ID: 11237490
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Multivariate analysis of the prognostic value of CEA and CA 19-9 serum levels in colorectal cancer.
    Reiter W; Stieber P; Reuter C; Nagel D; Lau-Werner U; Lamerz R
    Anticancer Res; 2000; 20(6D):5195-8. PubMed ID: 11326694
    [TBL] [Abstract][Full Text] [Related]  

  • 46. CEA as a prognostic factor in colorectal cancer.
    Filella X; Molina R; Piqué JM; Grau JJ; Garcia-Valdecasas JC; Biete A; Novell F; Astudillo E; Bordas JM; Campo E
    Anticancer Res; 1994; 14(2B):705-8. PubMed ID: 8010730
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Utility of CA19-9 and CEA as tumor marker in colorectal cancer--comparison between serum level and distribution].
    Okuda K; Kodaira S; Watanabe M; Takami H; Teramoto T; Abe O; Iri H; Ino Y; Hirohashi S
    Nihon Gan Chiryo Gakkai Shi; 1986 Jun; 21(5):969-77. PubMed ID: 3463631
    [No Abstract]   [Full Text] [Related]  

  • 48. [Diagnostic and prognostic value of CEA and GICA in colo-rectal tumors. A caseload contribution].
    Lasagna B; Balbo G; De Paolis P; Sacchetti M
    Minerva Med; 1990 Nov; 81(11):769-71. PubMed ID: 2255411
    [TBL] [Abstract][Full Text] [Related]  

  • 49. The correlation between serum VEGF levels and known prognostic risk factors in colorectal carcinoma.
    Beştaş R; Kaplan MA; Işikdoğan A
    Hepatogastroenterology; 2014; 61(130):267-71. PubMed ID: 24901122
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Significance of CEA and CA242 in the diagnosis of colorectal carcinoma].
    Wu J; Yu H; Shao Y
    Zhonghua Zhong Liu Za Zhi; 1995 Nov; 17(6):438-40. PubMed ID: 8697997
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Increase in both CEA and CA19-9 in sera is an independent prognostic indicator in colorectal carcinoma.
    Nozoe T; Rikimaru T; Mori E; Okuyama T; Takahashi I
    J Surg Oncol; 2006 Aug; 94(2):132-7. PubMed ID: 16847905
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Distributions in CEA doubling time differ in patients with recurrent colorectal carcinomas.
    Yamamoto M; Maehara Y; Sakaguchi Y; Mine H; Yamanaka T; Korenaga D; Okamura T
    Hepatogastroenterology; 2004; 51(55):147-51. PubMed ID: 15011851
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Colorectal cancer. Biochemical markers.
    Cooper EH; O'Quigley JO
    Recent Results Cancer Res; 1982; 83():67-76. PubMed ID: 6127760
    [No Abstract]   [Full Text] [Related]  

  • 54. Angiogenic growth factors in maternal and fetal serum in pregnancies complicated by intrauterine growth restriction.
    Wallner W; Sengenberger R; Strick R; Strissel PL; Meurer B; Beckmann MW; Schlembach D
    Clin Sci (Lond); 2007 Jan; 112(1):51-7. PubMed ID: 16928195
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Increased serum level of sialyl Lewis(x) antigen in blood from the tumor drainage vein in patients with non-polypoid growth type of colorectal cancer.
    Nakagoe T; Sawai T; Tsuji T; Jibiki M; Ohbatake M; Nanashima A; Yamaguchi H; Kurosaki N; Yasutake T; Ayabe H; Arisawa K
    J Exp Clin Cancer Res; 2001 Mar; 20(1):85-90. PubMed ID: 11370835
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Prognostic value of preoperative serum CEA level compared to clinical staging. IV. Histological grading and tumor type in colorectal and gastric cancer.
    Bogenschütz O; Brümmendorf T; Staab HJ; Anderer FA; Kieninger G
    J Surg Oncol; 1986 Jul; 32(3):165-73. PubMed ID: 3736053
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Regulation of vascular endothelial growth factor-A and its soluble receptor sFlt-1 by luteinizing hormone in vivo: implication for ovarian follicle angiogenesis.
    Gutman G; Barak V; Maslovitz S; Amit A; Lessing JB; Geva E
    Fertil Steril; 2008 Apr; 89(4):922-6. PubMed ID: 18343373
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Prognostic Nutritional Index Predicts Severe Complications, Recurrence, and Poor Prognosis in Patients With Colorectal Cancer Undergoing Primary Tumor Resection.
    Tokunaga R; Sakamoto Y; Nakagawa S; Miyamoto Y; Yoshida N; Oki E; Watanabe M; Baba H
    Dis Colon Rectum; 2015 Nov; 58(11):1048-57. PubMed ID: 26445177
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Clinical significance of the preoperative plasma carcinoembryonic antigen (CEA) level in patients with carcinoma of the large bowel.
    Blake KE; Dalbow MH; Concannon JP; Hodgson SE; Brodmerkel GJ; Panahandeh AH; Zimmerman K; Headings JJ
    Dis Colon Rectum; 1982; 25(1):24-32. PubMed ID: 7056138
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Pretreatment serum levels of cytokines and cytokine receptors in patients with non-small cell lung cancer, and correlations with clinicopathological features and prognosis. M-CSF - an independent prognostic factor.
    Kaminska J; Kowalska M; Kotowicz B; Fuksiewicz M; Glogowski M; Wojcik E; Chechlinska M; Steffen J
    Oncology; 2006; 70(2):115-25. PubMed ID: 16645324
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.